| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Scientific Officer
1 company
Nuss John serves as a Chief Scientific Officer at VTYX. Across recent SEC filings that breaks down to 0 buys and 28 sells. Those positions are worth an estimated $3.8M at current prices.
Historically, Nuss John's trades have earned a strong insider score of 79/100 across 15 rated trades. Over a 12-month horizon, 78.6% of those trades were profitable, with an average 12-month return of +55.8%.
The biggest single holding is VTYX (~$3.8M) as Chief Scientific Officer. The recent filings there lean toward selling, a net 266,933 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 | VTYX Ventyx Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 10,000 | $34.35 | $343,467.20 | -3.9% | -5.9% | -85.6% | |
| May 3, 2023 | VTYX Ventyx Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 10,000 | $38.64 | $386,370.67 | -3.9% | -4.8% | -87.4% | |
| Apr 3, 2023 | VTYX Ventyx Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 30,000 | $32.87 | $986,232.79 | -10.9% | +23.2% | -84.0% | |
| Dec 22, 2022 | VTYX Ventyx Biosciences, Inc. | Chief Scientific Officer | Sell | 13,812 | $31.61 | $436,653.95 | -5.3% | +18.3% | -93.1% | |
| Dec 13, 2022 | VTYX Ventyx Biosciences, Inc. | Chief Scientific Officer | Sell | 35,000 | $34.32 | $1,201,077.50 | -13.5% | +11.4% | -93.1% | |
| Dec 5, 2022 | VTYX Ventyx Biosciences, Inc. | Chief Scientific Officer | Sell | 50,000 | $28.23 | $1,411,311.41 | -16.2% | +56.1% | -92.5% |